- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AZD8233
Total 82 results
-
AstraZenecaCompleted
-
AstraZenecaParexelCompleted
-
AstraZenecaParexelTerminated
-
AstraZenecaParexelCompleted
-
AstraZenecaCompletedHyperlipidaemiaDenmark, Netherlands, Spain, Czechia, United States, Slovakia, Hungary, Poland
-
AstraZenecaCompleted
-
AstraZenecaQuotient SciencesCompletedHealthy VolunteersUnited Kingdom
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
AstraZenecaCompletedAdvanced Solid MalignanciesRussian Federation, Germany
-
AstraZenecaCompletedHealthyUnited Kingdom
-
AstraZenecaCompletedMild Cognitive Impairment | Mild Alzheimer's DiseaseUnited States
-
AstraZenecaTerminated
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseBulgaria, Germany, Hungary, Finland, Slovakia
-
AstraZenecaCompletedAsthmaUnited States, Germany, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseDenmark, Finland, Norway, Netherlands
-
AstraZenecaCompletedHealthy Volunteers | Mass Balance StudyUnited States
-
AstraZenecaCompletedHealthyUnited Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Poland
-
AstraZenecaCompleted
-
University of EdinburghNHS LothianCompletedFibrosis | Lung CancerUnited Kingdom
-
AstraZenecaEli Lilly and CompanyTerminatedAlzheimer's DiseaseUnited States, Spain, Australia, Belgium, Korea, Republic of, United Kingdom, Germany, Poland, Canada, Japan, Romania, France, Puerto Rico, Hungary
-
AstraZenecaCompletedTourette SyndromeUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompletedHealthy Volunteers | Pharmacologic ActionUnited States
-
AstraZenecaEli Lilly and CompanyCompleted
-
AstraZenecaCompletedHepatic ImpairmentUnited States, Bulgaria, Slovakia
-
AstraZenecaCompleted
-
AstraZenecaCompletedHealthy VolunteerJapan
-
AstraZenecaWithdrawnCystic FibrosisNetherlands, Poland, Spain, Canada
-
AstraZenecaEli Lilly and CompanyTerminatedAlzheimer´s DiseaseUnited States, Spain, Belgium, Australia, Hungary, Korea, Republic of, Canada, Germany, Japan, Romania, France, Poland, United Kingdom, Puerto Rico, Italy
-
AstraZenecaCompleted
-
AstraZenecaRecruitingBreast Cancer | Ovarian Cancer | Endometrial Cancer | Biliary Tract CarcinomaUnited States, Spain, Australia, United Kingdom, Korea, Republic of, Belgium, Canada, China, Japan, Taiwan, Thailand, Hungary, Poland, Netherlands
-
AstraZenecaCompletedHER2-negative Breast CancerMexico, United Kingdom, Georgia
-
AstraZenecaEli Lilly and CompanyTerminatedAlzheimer's DiseaseUnited States, Spain, Korea, Republic of, Italy, Portugal, China, Taiwan, Czechia, Japan, Poland, France, Netherlands, United Kingdom, Germany, Russian Federation, Canada, Mexico, Denmark
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited Kingdom
-
AstraZenecaParexelRecruitingHealthy ParticipantsUnited States, United Kingdom, Germany
-
AstraZenecaCompletedTolerabilityUnited States
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
AstraZenecaCompletedHealthy | Overweight | MaleUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaTerminated
-
AstraZenecaCompletedBrain Distribution of [11C]AZ12807110 and AZD5213Sweden
-
AstraZenecaWithdrawn
-
AstraZenecaCompletedHealthy Japanese Young and Elderly Male and Non-fertile Female VolunteersJapan
-
AstraZenecaCompletedHealthy Elderly Volunteers | Mild-to-moderate Alzheimer's Disease PatientsUnited States
-
AstraZenecaTerminatedBreast NeoplasmKorea, Republic of, Germany, Taiwan